What is the main business of Telses?

The main business activity of Telses focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on September 23, 2002.

Where is the headquarters located?

The headquarters is located at: ul. Jabłoniowa 22B, 80-175 Gdańsk.

What is the share capital?

The share capital of the company is PLN 100,000 (approx. $27,012).

What period do the latest financial data cover?

The latest available financial statement covers the period from August 1, 2023 to December 31, 2023.

Telsessp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Suspended

Registry date

2002-09-23

Share capital

100,000.00 PLN

Registered address

ul. Jabłoniowa 22B/5, 80-175 Gdańsk, Poland

Financials

Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.

Revenue history (in k)

Filing timeliness

No financial statement for 2024 – the filing deadline has passed. 3 of 6 financial statements were filed late (the longest delay 232 days for 2023), 1 not filed.

2024not filed
202304/03/2025
2022not filed
202129/09/2022
202015/12/2021
201903/09/2020

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Industry

Trademarks

Telses currently holds no active trademarks with the Polish Patent Office. 1 mark has expired or was not registered. The first mark was filed in 1996.

Mark	Number	Classes	Status	Protected until
TELSES	Z.157154	0, 9, 42	Expired	–

Mark	Protected until
TELSES	–

Authorized Representatives

Barbara Ekert – Attorney-in-fact (sole)

Lucyna Ewa Naruszewicz – Vice President of the Management Board

Marek Naruszewicz – President of the Management Board

Manner of representation

Each member of the management board is independently authorised to make declarations and sign on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Lucyna Ewa Naruszewiczage 45	24	$3,241.49	12%
Marek Naruszewiczage 72	176	$23,770.93	88%

Marek Naruszewicz and Lucyna Ewa Naruszewicz hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Bank accounts

Was a VAT taxpayer from 2002-10-01 to 2025-06-09.

Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Olympus Polskasp. z o.o.	$77,594,927.17	olympus.pl
Cirrosp. z o.o.	$20,863,166.14	cirro.pl
Livistosp. z o.o.	$17,956,135.04	livisto.pl
ODA Medicalsp. z o.o.	$9,414,794.43	odamedical.pl
Diather Petrusewiczsp. k.	$6,475,149.95	diather.pl
Dutchmed Plsp. z o.o.	$6,460,098.71	dutchmed.pl
Vet-Animalsp. z o.o.	$3,655,323.77	vet-animal.pl
Mikamedsp. z o.o.	$1,938,472.05	mikamed.pl
Optimed Pro-Office Cirrosp. j.	$1,276,876.90	cirro.pl
Beokasp. z o.o.	–	beoka.pl

Change history

Date	Event
2025-03-05	Business suspended
2025-02-24	Business resumed
2021-09-08	Address change (Al. Rzeczypospolitej 8/216, 80-369, Gdańsk → Ul. Jabłoniowa 22b/5, 80-175, Gdańsk)
2021-08-01	Business suspended
2019-08-19	Address change (Czarny Dwór 6/33, 80-365, Gdańsk → Al. Rzeczypospolitej 8/216, 80-369, Gdańsk)

FAQ

Last updated: 2026-04-05